Palatin Technologies (PTN) Prepaid Assets (2011 - 2026)
Palatin Technologies' (PTN) quarterly Prepaid Assets came in at $458539.0 in Q1 2026, up 3.7% YoY from $442178.0 in Q1 2025, and down 66.16% on a QoQ basis from $1.4 million in Q4 2025.
Palatin Technologies (PTN) Prepaid Assets (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 15 years of Prepaid Assets data on file, last reported at $458539.0 in Q1 2026.
- Quarterly Prepaid Assets rose 3.7% year-over-year to $458539.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458539.0 (up 3.7% YoY) and the FY2025 annual result came in at $325695.0, up 34.43% from the prior year.
- Prepaid Assets slipped to $458539.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.7 million in Q1 2022 to a low of $190468.0 in Q3 2025.
- A 5-year average of $1.1 million and a median of $458539.0 in 2026 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets plunged 88.82% — and 2025, when it soared 435.33%.
- Tracing PTN's Prepaid Assets over 5 years: stood at $2.1 million in 2022, then sank by 80.54% to $413954.0 in 2023, then slumped by 38.85% to $253113.0 in 2024, then soared by 435.33% to $1.4 million in 2025, then sank by 66.16% to $458539.0 in 2026.
- The last three Prepaid Assets figures came in at $458539.0 (Q1 2026), $1.4 million (Q4 2025), and $190468.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458,539.00 |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 190,468.00 |
| Jun 30, 2025 | 325,695.00 |
| Mar 31, 2025 | 442,178.00 |
| Dec 31, 2024 | 253,113.00 |
| Sep 30, 2024 | 228,435.00 |
| Jun 30, 2024 | 242,272.00 |
| Mar 31, 2024 | 254,554.00 |
| Dec 31, 2023 | 413,954.00 |
| Sep 30, 2023 | 1.33 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 3.06 Mn |